Search results
10 Best Performing Biotech ETFs in 2024
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just...
Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
BioPharma Dive via Yahoo Finance· 6 days agoRemix is aligned with Roche and Johnson & Johnson. Skyhawk has several collaborations under its...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 3 days ago, opens new tab on Thursday raised its annual profit and revenue forecast on the back of strong...
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Benzinga via Yahoo Finance· 3 days agoThe investigational...
Endeavor pulls in $132M to back cancer, lung disease drugs
BioPharma Dive via Yahoo Finance· 4 days agoLed by the founder of a biotech Celgene acquired for $7 billion, the startup is developing two...
Merck Raises 2024 Profit Forecast on Strong Sales of Cancer Drug Keytruda
US News & World Report· 3 days agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past few years and is expected to top $30 billion in sales by 2026 before losing exclusivity toward ...
APA Corp Leads Smead Value Fund's Q1 2024 Portfolio Adjustments with 0.68% Impact
GuruFocus.com via Yahoo Finance· 2 days agoThe top holdings are notably concentrated in 7.46% in Lennar Corp (NYSE:LEN), 6.75% in D.R. Horton...
APA Corp Leads Smead Value Fund's Q1 2024 Portfolio Adjustments
Guru Focus· 2 days agoInsights into Smead Value Fund (Trades, Portfolio)'s Latest Investment Moves and Stock Positions Smead Value Fund (Trades, Portfolio), managed by Smead Capital
S&P 500 Down Over 1%; Merck Increases 2024 Outlook - ATN International (NASDAQ:ATNI), Hertz Global...
Benzinga· 2 days agoIn trading on Thursday, communication services shares dipped by 5.3%. Top Headline Merck & Co., Inc...
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks via Yahoo Finance· 4 days agoPJP, it has heaviest allocation in the Healthcare sector --about 100% of the portfolio. When you...